• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Statins do not increase breast cancer risk in postmenopausal women

bySiwen LiuandSimon Pan
April 7, 2026
in Chronic Disease, Oncology, Pharma
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Statin use did not increase the risk of developing breast cancer among postmenopausal women.

Evidence Rating Level: 2 (Good)

While statins are commonly used lipid-lowering drugs in the prevention of cardiovascular disease, they may also play a role in preventing breast cancer, although the evidence is conflicting. This study thus investigated statin use and the risk of incident breast cancer as well as the subtype of breast cancer, in postmenopausal women. The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA) was a prospective cohort study that included postmenopausal women undergoing clinical or screening mammography from four hospitals between January 2011 and March 2013. Participants were followed until the date of invasive breast cancer diagnosis, date of death, or December 31, 2019, whichever came first. In total, 35,315 participants were included in the study (median age [IQR], 62 [57, 67]). The median follow-up time was 6.6 years. In total, 25% of participants were statin users, of which 16% were prevalent statin users, and 9% were incident statin users. During eight years of follow-up, there were 785 incident invasive breast cancer cases reported. Incident or prevalent statin use was not significantly associated with risk of incident breast cancer (Adjusted hazard ratio [HRadj] 1.24, 95% CI 0.89–1.72, and HRadj 0.90, 95% CI 0.73–1.11, respectively). Incident or prevalent statin use was also not significantly associated with subtype-specific risk of breast cancer. Overall, this study found statin use did not increase the risk of developing breast cancer among postmenopausal women, suggesting statins are safe medications in the context of breast cancer for this population. Future studies with longer follow-up are needed to confirm the study findings.

Click here to read the study in Cancer Causes & Control

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

2 Minute Medicine Rewind April 6, 2026

Susie Wiles’ breast cancer diagnosis drives national screening surge

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

Tags: Breast Cancergynecologypostmenopausalstatin
Previous Post

Roche and NVIDIA deploy the pharmaceutical industry’s largest artificial intelligence factory

RelatedReports

Stochastic resonance stimulation may decrease apnea of prematurity
Weekly Rewinds

2 Minute Medicine Rewind April 6, 2026

April 6, 2026
High frequency of germline mutations observed in triple negative breast cancers
The Scan by 2 Minute Medicine®

Susie Wiles’ breast cancer diagnosis drives national screening surge

March 25, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Artificial Intelligence

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

March 25, 2026
Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Oncology

Delaying pegfilgrastim administration reduces bone pain in breast cancer patients 

March 23, 2026

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Statins do not increase breast cancer risk in postmenopausal women
  • Roche and NVIDIA deploy the pharmaceutical industry’s largest artificial intelligence factory
  • Apolipoprotein E mimetic peptide CN-105 may be safe and feasible for delirium prevention in older surgical patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.